Syndax Pharmaceuticals, Inc. (SNDX)
19.69
-0.94
(-4.56%)
USD |
NASDAQ |
Feb 20, 16:00
19.94
+0.25
(+1.27%)
After-Hours: 20:00
Syndax Pharmaceuticals EPS Diluted (Quarterly) : -0.7009 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -60.72M |
| Revenue (Quarterly) | 45.87M |
| Total Expenses (Quarterly) | 106.59M |
| Enterprise Value | 1.621B |
| Gross Profit Margin (Quarterly) | 95.42% |
| Profit Margin (Quarterly) | -132.4% |
| Earnings Yield | -18.36% |
| Normalized Earnings Yield | -18.36 |